The Zhitong Finance App learned that on Tuesday, LEGN.US (LEGN.US) rose nearly 6% to $34.02. According to reports, Legend Biotech is a global clinical-stage biopharmaceutical company focusing on the development of novel cell therapies, especially in the field of oncology. The company was founded in 2015, is headquartered in the Cayman Islands, and has branches in the US, China, etc. Its core product is the CAR-T therapy CARVYKTI® (Sidakiolenol), which is used to treat multiple myeloma (MM), developed and commercialized in cooperation with Janssen (Janssen), a subsidiary of Johnson & Johnson.

Zhitongcaijing · 04/15 16:09
The Zhitong Finance App learned that on Tuesday, LEGN.US (LEGN.US) rose nearly 6% to $34.02. According to reports, Legend Biotech is a global clinical-stage biopharmaceutical company focusing on the development of novel cell therapies, especially in the field of oncology. The company was founded in 2015, is headquartered in the Cayman Islands, and has branches in the US, China, etc. Its core product is the CAR-T therapy CARVYKTI® (Sidakiolenol), which is used to treat multiple myeloma (MM), developed and commercialized in cooperation with Janssen (Janssen), a subsidiary of Johnson & Johnson.